Fortbildung bei der DGRA e.V.
DGRA-Workshop
Advanced Therapy Medicinal Product Development and Regenerative Medicine
25. - 26. November 2008 in Langen
Termine
Dienstag, 25. November 2008 | 12.00 Uhr bis 19.00 Uhr
Mittwoch, 26. November 2008 | 09.00 Uhr bis 14.40 Uhr Termin in den eigenen Kalender übertragen
Veranstaltungsort
Paul-Ehrlich-Institut
Paul-Ehrlich-Straße 51-59, 63225 Langen
Tel.: 06103 77 0
Routenplaner
Download
-
Programmvorschau Änderungen vorbehalten
Programm am 25. November 2008
12.00 Welcome K. Cichutek, Vice-President, PEI 12.10 Advanced therapy medicinal products (ATMP) legislation, regulation, certification M. Terberger – tbc 12.40 Session 1: Legislation, incentives and advice Chair: C. Schröder (PEI) 12.45 Implementation of advanced therapy regulations at EMEA P. Celis 13.10 Implementation of ATMP legislation in national law A. Dwenger 13.35 Micro, small and medium-sized enterprises (SME) M. Carr 14.00 Coffee Break 15.00 Session 2: Regulatory requirements for marketing authorization, dossier requirements Chair: U. Granzer (Granzer Consulting), J. Scherer (PEI) 15.05 Requirements Annex I as amended (2003/63/EC) – requirements for MAA M. Terberger – tbc 15.30 Risk management plan and pharmacovigilance B. Keller-Stanislawski 15.55 Enviromental Risk Assessment Chr. Buchholz 16.20 Coffee Break 17.00 Session 3: Impact on stakeholders (with panel discussion) Chair: W. Schwerdtfeger (German Federal Ministry of Health), K. Cichutek (PEI) 17.05 Advanced Therapies Medicinal Products from the Governmental Point of View S. Brandt 17.20 Comments of industry regarding the regulatory requirements H. Joseph 17.35 Position of industry under the special consideration of SMEs B. Sickmüller 17.50 Reimbursement P. T. Sawicki 18.05 Panel Discussion 19.00 Reception 20.00 Dinner Programm am 26. November 2008
9.00 Challenges with advanced therapies C. Schneider 9.30 Session 4: Quality aspects of ATMPs Chair: G. Dallmann (NDA), R. Seitz (PEI) 9.35 Quality requirements for cell-based medicinal products P. Salmikangas 9.55 Quality requirements for gene therapy products S. Schüle 10.20 International harmonisation for gene therapy medicinal products S. Longhurst 10.45 Microbial safety T. Montag-Lessing 11.10 Virus safety of advanced therapy medicinal products J. Blümel 11.35 Break 12.35 Session 5: (Non)-Clinical aspects of ATMPs Chair: A. Hilger (PEI), M. Schüssler-Lenz, (PEI) Non-clinical models for cell-based medicinal products E. Flory 13.00 Clinical requirements for tissue engineered products. Challenges and possible solutions R. Mačiulaitis 13.25 Design of pivotal clinical trials for gene therapy medicinal products G. Narayanan 13.50 Clinical follow-up and traceability B. Klug 14.15 Comments of industry regarding requirements for (non)-clinical trials under special consideration of ATMPs already legally on the market
A. Emmendörfer14:40 Closing remarks K. Cichutek -
Kostenbeitrag und Stornierungen
Fees (Conference and Dinner):
For DGRA members: € 250,-
For non-members: € 350,-Es gelten die allgemeinen Veranstaltungshinweise / AGB's.
-
Anreise und Unterkunft
A limited number of rooms are available for participants at special rates in the hotels listed below. Bookings under the special condition are requested until 25 October 2008.
When making reservations please refer to this event.
ACHAT Hotel
Robert-Bosch-Str. 58
D- 63225 Langen (Germany)
Phone: + 49 (0) 6103 / 7560
Fax: + 49 (0) 6103 / 756999
www.achathotels.de
langen@achat-hotel.de
Hotel Steigenberger MAXX Langen
SRS Worldhotels
Robert-Bosch-Str. 26
D-63225 Langen (Germany)
Phone: + 49 (0) 6103 / 9720
Fax: + 49 (0) 6103 / 972555
www.srs-worldhotels.com
Frankfurt-langen@steigenberger.de